Chronic Bronchitis

Order diagnostic spirometry after bronchodilator administration when chronic cough, sputum production, dyspnea, or relevant exposure history raises concern for COPD. A post-bronchodilator FEV1/FVC ratio <0.70 supports persistent airflow limitation; symptoms and examination alone do not reliably predict obstruction. ScienceDirect+2ScienceDirectSpirometry - an overview | ScienceDirect TopicsCDCWorld Trade Center Health Program best practices for ...ema europa euguideline-clinical-investigation-medicinal-products-treatment ...

Stage the spirometric severity only after confirming obstruction: GOLD 1, FEV1 at least 80% predicted; GOLD 2, 50% to <80%; GOLD 3, 30% to <50%; and GOLD 4, <30% predicted. Spirometric grade informs physiologic severity but should be interpreted with symptom burden and exacerbation history rather than used as a stand-alone treatment determinant. fda+2fda[PDF] Drug Development Tool Clinical Outcome Assessment Qualification ...ScienceDirectSpirometry - an overview | ScienceDirect Topicsema europa euguideline-clinical-investigation-medicinal-products-treatment ...

When an older patient has mild obstruction by the fixed ratio, assess whether the result is below the lower limit of normal when available. The fixed FEV1/FVC <0.70 criterion can overdiagnose COPD in older adults, whereas ATS/ERS-oriented approaches use the fifth-percentile lower limit of normal; this discrepancy matters most near the diagnostic threshold. Nature+3NaturePulmonary function testing in COPD: looking beyond the curtain of ...ema europa euguideline-clinical-investigation-medicinal-products-treatment ...CDC[PDF] A Proposed Algorithm for the Identification of Occupational COPD in ...CDC[PDF] An Algorithm for the Surveillance of Occupational COPD in ...

In patients with normal chest radiography and spirometry, prioritize cough-variant asthma, nonasthmatic eosinophilic bronchitis, reflux, and nasal disease as common chronic-cough triggers, particularly in nonsmokers. Nonasthmatic eosinophilic bronchitis is characterized by eosinophilic airway inflammation and is a distinct diagnostic branch from fixed COPD obstruction. ScienceDirect+1ScienceDirectGerman Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic coughjournal chestnetChronic Cough Due to Nonasthmatic Eosinophilic Bronchitis - CHEST

When asthma coexists with COPD, treat the asthma component first with emphasis on inhaled corticosteroid therapy, then address the COPD component with the usual stepwise inhaled approach. This is particularly relevant when bronchodilator reversibility, variable symptoms, or prior asthma history makes a pure fixed-obstruction label incomplete. CDCCDCWorld Trade Center Health Program best practices for ...

Take a structured occupational history that identifies work tasks, duration, intensity, and temporal relationships to vapors, gases, dusts, and fumes. Occupational COPD can overlap with other work-related airway disorders and evolve into fixed obstruction; no universally accepted exposure dose, duration, or latency threshold establishes causation. CDC+2CDC[PDF] A Proposed Algorithm for the Identification of Occupational COPD in ...CDCOccupational Chronic Obstructive Pulmonary DiseaseCDC[PDF] An Algorithm for the Surveillance of Occupational COPD in ...

For persistent dyspnea or exercise limitation after initial therapy, use dual long-acting bronchodilation with LABA/LAMA, retain a short-acting bronchodilator for relief, and add pulmonary rehabilitation. Pulmonary rehabilitation improves exercise tolerance, dyspnea, and health-related quality of life and is associated with reduced rehospitalization and mortality. BMJBMJChronic obstructive pulmonary disease (COPD) - BMJ Best Practice

For persistent exacerbations, escalate inhaled treatment with LABA/LAMA or LABA/LAMA/ICS according to the clinical treatment pathway, then consider targeted adjuncts. Roflumilast is dosed at 500 micrograms orally once daily in selected patients; azithromycin is recommended by major COPD strategies for patients who continue to exacerbate despite optimized inhaled therapy, with long-term adverse effects requiring deliberate benefit-harm assessment. BMJ+1BMJBenefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | ThoraxBMJChronic obstructive pulmonary disease (COPD) - BMJ Best Practice

Address modifiable drivers at each visit: smoking cessation, reduction of hazardous occupational and environmental exposures, and vaccination against influenza virus and Streptococcus pneumoniae are core COPD interventions. For severe COPD, assess whether oxygen therapy or ventilatory support is indicated; long-term oxygen therapy improves survival in severe COPD. BMJ+1BMJChronic obstructive pulmonary disease (COPD) - BMJ Best PracticeCDCWorld Trade Center Health Program best practices for ...

Classify an acute deterioration by treatment requirement: mild events can be controlled by increased usual medication; moderate events require systemic corticosteroids and/or antibiotics; severe events require hospitalization or result in death. This classification provides an immediate severity frame but does not replace assessment for hypoxemia, hypercapnia, or a competing acute diagnosis. ema europa euema europa euguideline-clinical-investigation-medicinal-products-treatment ...

At presentation, obtain pulse oximetry and assess arterial blood gases when oxygenation or ventilation is impaired or uncertain. Give oxygen for PaO2 <60 mmHg or oxygen saturation <90%, then repeat pulse oximetry and arterial blood gas measurements as clinically indicated because excessive oxygen can worsen hypercapnia. BMJ+1BMJChronic obstructive pulmonary disease (COPD) - BMJ Best PracticeBMJAcute exacerbation of chronic obstructive pulmonary disease - Management recommendations | BMJ Best Practice US

Most stable exacerbations can be managed as outpatients with short-acting bronchodilators, systemic corticosteroids, and antibiotics when indicated; patients with more severe events require hospitalization and may need ventilatory support. GOLD-based recommendations favor a 5-day systemic corticosteroid course, whereas ERS/ATS guidance permits treatment for up to 14 days. BMJ+1BMJAcute exacerbation of chronic obstructive pulmonary disease - Management recommendations | BMJ Best Practice USOxford AcademicManagement of chronic obstructive pulmonary disease: A review ...

Do not equate chronic sputum production with bacterial infection or an automatic indication for antibiotics. Acute bacterial exacerbation is a distinct regulatory and trial construct within COPD, while exacerbation treatment intensity is classified by the need for systemic corticosteroids, antibiotics, hospitalization, or ventilatory support. fda+1fdaAcute Bacterial Exacerbations of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease: Acute Bacterial Exacerbations of Chronic Bronchitis in Patients | FDAema europa euguideline-clinical-investigation-medicinal-products-treatment ...

Do not use normal spirometry to dismiss symptomatic tobacco-exposed patients, but do not apply COPD pharmacotherapy as though obstruction were present. Symptoms occur in current and former smokers without spirometric obstruction, and this population may not respond to COPD therapies. ScienceDirect+1ScienceDirectSpirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVCCDCRisk of Chronic Obstructive Pulmonary Disease and ...

When workplace exposure may be causal, document the exposure history before the patient changes jobs or retires. Occupational COPD adjudication is limited by uncertain dose, duration, latency, and spirometric definitions; contemporaneous task and exposure documentation is therefore clinically consequential. CDC+2CDC[PDF] A Proposed Algorithm for the Identification of Occupational COPD in ...CDCOccupational Chronic Obstructive Pulmonary DiseaseCDC[PDF] An Algorithm for the Surveillance of Occupational COPD in ...